NASDAQ:ERAS • US29479A1088
ChartMill assigns a Buy % Consensus number of 81% to ERAS. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-26 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-01-16 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-01-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-01-07 | Piper Sandler | Initiate | Overweight |
| 2025-12-09 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-11-14 | Guggenheim | Maintains | Buy -> Buy |
| 2025-10-16 | Stifel | Initiate | Buy |
| 2025-09-03 | B of A Securities | Downgrade | Buy -> Underperform |
| 2025-08-18 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2025-04-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-26 | Raymond James | Initiate | Outperform |
| 2025-03-21 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-03-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-07 | B of A Securities | Upgrade | Neutral -> Buy |
| 2024-11-18 | Jefferies | Initiate | Buy |
| 2024-11-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-25 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-10-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-14 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-08-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-28 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-05-20 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-02 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-03-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-11 | Capital One | Initiate | Overweight |
| 2024-01-05 | B of A Securities | Downgrade | Buy -> Neutral |
| 2023-11-29 | Mizuho | Maintains | Buy -> Buy |
| 2023-11-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-10-11 | HC Wainwright & Co. | Initiate | Buy |
17 analysts have analysed ERAS and the average price target is 10.51 USD. This implies a price decrease of -15.21% is expected in the next year compared to the current price of 12.39.
The consensus rating for ERASCA INC (ERAS) is 81.1765 / 100 . This indicates that analysts generally have a positive outlook on the stock.